BSE has listed 51,00,000 new equity shares of Ind-Swift Laboratories Ltd. (Scrip Code: 532305) issued to promoters on a preferential basis pursuant to the conversion of warrants. These shares are permitted to trade on the Exchange with effect from Friday, April 17, 2026.

Key Points

• 51,00,000 equity shares of Rs. 10/- each issued at a premium of Rs. 111/- (issue price Rs. 121/-) to promoters
• Shares allotted via preferential basis on conversion of warrants
• New shares rank pari-passu with existing equity shares
• Distribution numbers: 81611559 to 86711558
• ISIN: INE915B01019
• All 51,00,000 new shares are under lock-in until October 20, 2027

Regulatory Changes

No new regulatory changes introduced. This is a standard listing notice pursuant to preferential allotment rules under SEBI regulations.

Compliance Requirements

• Trading members are informed of the new securities available for trading from April 17, 2026
• The lock-in restriction on all 51,00,000 shares must be observed until October 20, 2027

Important Dates

• Date of Allotment: February 24, 2026
• Effective Trading Date: April 17, 2026 (Friday)
• Lock-in Expiry: October 20, 2027

Impact Assessment

The listing adds 51,00,000 shares to Ind-Swift Laboratories Ltd.’s equity base, all held by promoters and subject to lock-in until October 2027. Since these shares cannot be traded until the lock-in expires, the immediate impact on market liquidity and free float is minimal. The preferential allotment at Rs. 121/- per share (Rs. 10 face value + Rs. 111 premium) reflects the terms agreed upon at warrant issuance. Existing shareholders should note the increase in total equity capital and the corresponding dilution effect.